ARMATA PHARMACEUTICALS, INC. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/124d3504-73b0-43f0-bf23-09203e355ab0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-173.8M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-034532 |
| FY 2024 | $-18.9M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003406 |
| FY 2023 | $-69.0M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003706 |
| FY 2022 | $-36.9M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004014 |
| FY 2021 | $-23.2M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003845 |
| FY 2020 | $-22.2M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003202 |
| FY 2019 | $-19.5M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002943 |
| FY 2018 | $-16.7M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002943 |
| FY 2017 | $-12.8M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-014652 |
| FY 2016 | $-18.8M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-016833 |
| FY 2015 | $-516.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091546 |
| FY 2014 | $23.1M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-023071 |
| FY 2013 | $-64.6M | 2013-01-01 – 2013-12-31 | evidence 0001144204-15-023064 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).